Annual EBIT:
-$442.90M+$129.06M(+22.56%)Summary
- As of today, BBIO annual earnings before interest & taxes is -$442.90 million, with the most recent change of +$129.06 million (+22.56%) on December 31, 2024.
- During the last 3 years, BBIO annual EBIT has risen by +$96.77 million (+17.93%).
- BBIO annual EBIT is now -910.76% below its all-time high of -$43.82 million, reached on December 31, 2017.
Performance
BBIO EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBIT:
-$144.02M-$16.55M(-12.99%)Summary
- As of today, BBIO quarterly earnings before interest & taxes is -$144.02 million, with the most recent change of -$16.55 million (-12.99%) on June 30, 2025.
- Over the past year, BBIO quarterly EBIT has dropped by -$91.41 million (-173.77%).
- BBIO quarterly EBIT is now -912.76% below its all-time high of $17.72 million, reached on June 30, 2022.
Performance
BBIO Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
-$649.10M-$91.41M(-16.39%)Summary
- As of today, BBIO TTM earnings before interest & taxes is -$649.10 million, with the most recent change of -$91.41 million (-16.39%) on June 30, 2025.
- Over the past year, BBIO TTM EBIT has dropped by -$274.56 million (-73.31%).
- BBIO TTM EBIT is now -1430.06% below its all-time high of -$42.42 million, reached on March 31, 2018.
Performance
BBIO TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
BBIO EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +22.6% | -173.8% | -73.3% |
| 3Y3 Years | +17.9% | -912.8% | -44.1% |
| 5Y5 Years | -58.3% | -14.8% | -52.4% |
BBIO EBIT Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -9.6% | +22.6% | -1035.0% | +39.1% | -87.7% | at low |
| 5Y | 5-Year | -58.3% | +22.6% | -912.8% | +39.1% | -87.7% | at low |
| All-Time | All-Time | -910.8% | +22.6% | -912.8% | +39.1% | -1430.1% | at low |
BBIO EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$144.02M(-13.0%) | -$649.10M(-16.4%) |
| Mar 2025 | - | -$127.47M(+46.1%) | -$557.68M(-25.9%) |
| Dec 2024 | -$442.90M(+22.6%) | -$236.41M(-67.4%) | -$442.90M(-24.2%) |
| Sep 2024 | - | -$141.19M(-168.4%) | -$356.55M(+4.8%) |
| Jun 2024 | - | -$52.61M(-314.6%) | -$374.54M(+18.9%) |
| Mar 2024 | - | -$12.69M(+91.5%) | -$462.04M(+19.2%) |
| Dec 2023 | -$571.96M(-41.5%) | -$150.06M(+5.7%) | -$571.96M(-5.4%) |
| Sep 2023 | - | -$159.18M(-13.6%) | -$542.48M(-7.7%) |
| Jun 2023 | - | -$140.11M(-14.3%) | -$503.67M(-45.6%) |
| Mar 2023 | - | -$122.61M(-1.7%) | -$345.84M(+14.4%) |
| Dec 2022 | -$404.21M(+25.1%) | -$120.58M(-0.2%) | -$404.21M(+3.9%) |
| Sep 2022 | - | -$120.37M(-779.3%) | -$420.78M(+6.6%) |
| Jun 2022 | - | $17.72M(+109.8%) | -$450.36M(+19.5%) |
| Mar 2022 | - | -$180.99M(-32.0%) | -$559.32M(-3.6%) |
| Dec 2021 | -$539.68M | -$137.15M(+8.5%) | -$539.68M(-2.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | -$149.95M(-64.4%) | -$526.59M(-6.2%) |
| Jun 2021 | - | -$91.23M(+43.5%) | -$495.88M(+6.5%) |
| Mar 2021 | - | -$161.34M(-30.1%) | -$530.11M(-13.1%) |
| Dec 2020 | -$468.83M(-67.5%) | -$124.06M(-4.0%) | -$468.83M(-10.1%) |
| Sep 2020 | - | -$119.24M(+5.0%) | -$425.88M(-16.6%) |
| Jun 2020 | - | -$125.46M(-25.4%) | -$365.19M(-17.0%) |
| Mar 2020 | - | -$100.07M(-23.4%) | -$312.13M(-11.5%) |
| Dec 2019 | -$279.82M(-67.7%) | -$81.11M(-38.5%) | -$279.82M(-13.4%) |
| Sep 2019 | - | -$58.55M(+19.1%) | -$246.77M(-7.7%) |
| Jun 2019 | - | -$72.39M(-6.8%) | -$229.14M(-19.2%) |
| Mar 2019 | - | -$67.77M(-41.0%) | -$192.25M(-15.2%) |
| Dec 2018 | -$166.90M(-280.9%) | -$48.06M(-17.4%) | -$166.90M(-40.4%) |
| Sep 2018 | - | -$40.92M(-15.3%) | -$118.84M(-52.5%) |
| Jun 2018 | - | -$35.50M(+16.3%) | -$77.92M(-83.7%) |
| Mar 2018 | - | -$42.42M | -$42.42M |
| Dec 2017 | -$43.82M | - | - |
FAQ
- What is BridgeBio Pharma, Inc. annual earnings before interest & taxes?
- What is the all-time high annual EBIT for BridgeBio Pharma, Inc.?
- What is BridgeBio Pharma, Inc. annual EBIT year-on-year change?
- What is BridgeBio Pharma, Inc. quarterly earnings before interest & taxes?
- What is the all-time high quarterly EBIT for BridgeBio Pharma, Inc.?
- What is BridgeBio Pharma, Inc. quarterly EBIT year-on-year change?
- What is BridgeBio Pharma, Inc. TTM earnings before interest & taxes?
- What is the all-time high TTM EBIT for BridgeBio Pharma, Inc.?
- What is BridgeBio Pharma, Inc. TTM EBIT year-on-year change?
What is BridgeBio Pharma, Inc. annual earnings before interest & taxes?
The current annual EBIT of BBIO is -$442.90M
What is the all-time high annual EBIT for BridgeBio Pharma, Inc.?
BridgeBio Pharma, Inc. all-time high annual earnings before interest & taxes is -$43.82M
What is BridgeBio Pharma, Inc. annual EBIT year-on-year change?
Over the past year, BBIO annual earnings before interest & taxes has changed by +$129.06M (+22.56%)
What is BridgeBio Pharma, Inc. quarterly earnings before interest & taxes?
The current quarterly EBIT of BBIO is -$144.02M
What is the all-time high quarterly EBIT for BridgeBio Pharma, Inc.?
BridgeBio Pharma, Inc. all-time high quarterly earnings before interest & taxes is $17.72M
What is BridgeBio Pharma, Inc. quarterly EBIT year-on-year change?
Over the past year, BBIO quarterly earnings before interest & taxes has changed by -$91.41M (-173.77%)
What is BridgeBio Pharma, Inc. TTM earnings before interest & taxes?
The current TTM EBIT of BBIO is -$649.10M
What is the all-time high TTM EBIT for BridgeBio Pharma, Inc.?
BridgeBio Pharma, Inc. all-time high TTM earnings before interest & taxes is -$42.42M
What is BridgeBio Pharma, Inc. TTM EBIT year-on-year change?
Over the past year, BBIO TTM earnings before interest & taxes has changed by -$274.56M (-73.31%)